Department of Medicine
-
March 17, 2022
Study compares kidney injury risk for COVID, flu patients
A Vanderbilt study found that renin-angiotensin-aldosterone system (RAASi) inhibitor drugs, which are commonly used to regulate high blood pressure, do not disproportionately increase the risk of acute kidney injury (AKI) in patients with COVID-19 compared to patients hospitalized with influenza. -
March 17, 2022
Talbot named to infection prevention society’s leadership
Vanderbilt's Tom Talbot, MD, MPH, was recently elected to serve in the leadership of the Society for Healthcare Epidemiology of America. -
March 16, 2022
Teamwork returns man with severe post-COVID complications to his life
A multidisciplinary team at Vanderbilt helped José Ontiveros cope with a long list of severe complications arising from his COVID-19i infection. -
March 14, 2022
Microbiome reflects COVID-19 severity
Characterization of the upper respiratory tract microbiome could help predict outcomes for COVID-19 infection, Vanderbilt researchers have discovered. -
March 10, 2022
Bots boost liver cancer outcome
Vanderbilt researchers report that robotic-assisted surgery is comparable, if not superior, to laparoscopic surgery for early-stage liver cancer patients. -
March 10, 2022
ICU study confirms safety of delabeling penicillin allergies
A Vanderbilt study shows that physicians can safely identify and disprove low-risk penicillin allergies using an oral amoxicillin challenge in consenting patients, even those in the intensive care unit who are recovering from critical illness. -
March 7, 2022
Study finds World Trade Center responders at higher risk for blood cancer-associated mutations
A study by Vanderbilt and New York City researchers found that 9/11 first responders to the World Trade Center have increased levels of mutations that escalate their risk for blood cancers or cardiovascular disease